New Lung Cancer Drug Cuts Death Risk by 54% in Trial
A breakthrough drug called Gotistobart has shown remarkable results in advanced lung cancer patients, reducing their risk of death by more than half. The trial results offer new hope for people facing one of the world's most challenging cancer diagnoses.